Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Current Leases (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Current Leases data on record, last reported at $9.4 million in Q4 2025.

  • For Q4 2025, Current Leases rose 706.41% year-over-year to $9.4 million; the TTM value through Dec 2025 reached $9.4 million, up 706.41%, while the annual FY2025 figure was $9.4 million, 706.41% up from the prior year.
  • Current Leases reached $9.4 million in Q4 2025 per ORGO's latest filing, up from $1.2 million in the prior quarter.
  • Across five years, Current Leases topped out at $13.0 million in Q3 2023 and bottomed at $611000.0 in Q1 2023.
  • Average Current Leases over 5 years is $6.7 million, with a median of $4.8 million recorded in 2025.
  • Peak YoY movement for Current Leases: tumbled 87.58% in 2023, then surged 706.41% in 2025.
  • A 5-year view of Current Leases shows it stood at $11.8 million in 2021, then fell by 26.12% to $8.7 million in 2022, then crashed by 87.58% to $1.1 million in 2023, then grew by 8.23% to $1.2 million in 2024, then soared by 706.41% to $9.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $9.4 million in Q4 2025, $1.2 million in Q3 2025, and $4.8 million in Q2 2025.